© Reuters. FILE PHOTO: The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022. REUTERS/Brendan McDermid/File Photo
(Reuters) – Consumer healthcare giant Haleon said on Monday that Pfizer (NYSE:) will sell about 630 million of its shares in the company, reducing the US drugmaker’s stake to about 24%.
